COGT
COGT
NASDAQ · Biotechnology

Cogent Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$35.84
+1.30 (+3.76%)
As of Jun 22, 9:51 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 16 84%
Hold 3 16%
Sell 0 0%
Price Target
Analyst Price Target +134.3% upside
Low Target $51.90
Average Target $83.97
High Target $108.57
Current Price $35.84
Current
$35.84
Target
$83.97
$51.90 $83.97 avg $108.57
Scenario Analysis
Bear Case
$51.90
44.8%
Low target
Base Case
$83.97
+134.3%
Avg target
Bull Case
$108.57
+202.9%
High target
Risk/Reward
4.5x
Highly favorable
Price in Context
52-Week High
$43.73
-18.0% from high
52-Week Low
$6.92
+417.9% from low
50-Day SMA
$37.85
-5.3% vs SMA
200-Day SMA
$20.09
+78.4% vs SMA
RSI (14)
53.0
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%